Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
Drug Dissolution: Requirements and Profile Comparison01:14

Drug Dissolution: Requirements and Profile Comparison

The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...
Modified-Release Drug Delivery Systems: Drug Release Characteristics01:22

Modified-Release Drug Delivery Systems: Drug Release Characteristics

Drug release from modified-release dosage forms is designed to achieve specific therapeutic effects by controlling the rate and extent of drug release. The classification of these drug release systems is based on key pharmacokinetic assumptions: drug disposition follows first-order kinetics, drug release is the rate-limiting step in absorption, and the released drug is rapidly and completely absorbed.There are four major models of drug release patterns. The first model is the slow zero-order...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Emerging role of antioxidants in Alzheimer's disease: Insight into physiological, pathological mechanisms and management.

Pharmaceutical science advances·2026
Same author

Deferoxamine halt rotenone-induced Parkinson's like symptoms in experimental rats: biochemical, neuroinflammatory, neurotransmitters, and histological evidence.

Drug and chemical toxicology·2025
Same author

Postbiotics as a therapeutic tool in Alzheimer's disease: Insights into molecular pathways and neuroprotective effects.

Ageing research reviews·2025
Same author

Retraction notice to "Cladribine induces apoptosis, neuroinflammation, mitochondrial oxidative stress, tau phosphorylation and Aβ (1-42) pathway in the hippocampus: An in vivo approach" [J. Chem. Neuroanat. 133 (2023) 102340].

Journal of chemical neuroanatomy·2024
Same author

Development of nanoemulgel of 5-Fluorouracil for skin melanoma using glycyrrhizin as a penetration enhancer.

Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society·2024
Same author

A comprehensive review of small molecules targeting PI3K pathway: Exploring the structural development for the treatment of breast cancer.

Bioorganic chemistry·2024

Related Experiment Video

Updated: Jun 3, 2026

Quantifying Mixing using Magnetic Resonance Imaging
07:33

Quantifying Mixing using Magnetic Resonance Imaging

Published on: January 25, 2012

Meloxicam carbopol-based gels: characterization and evaluation.

Rashmi Sareen1, Sandeep Kumar, G D Gupta

  • 1Abhilashi College of Pharmacy, Tanda, Ner Chowk, Mandi (HP), India. sareenrashmi@gmail.com

Current Drug Delivery
|April 2, 2011
PubMed
Summary

This study developed meloxicam hydrogels for topical use, finding sesame oil enhanced drug release. Optimized formulations show potential for effective topical pain management.

More Related Videos

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
07:32

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Published on: August 28, 2015

Related Experiment Videos

Last Updated: Jun 3, 2026

Quantifying Mixing using Magnetic Resonance Imaging
07:33

Quantifying Mixing using Magnetic Resonance Imaging

Published on: January 25, 2012

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
07:32

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Published on: August 28, 2015

Area of Science:

  • Pharmaceutical Sciences
  • Materials Science

Background:

  • Topical drug delivery systems are crucial for localized treatment.
  • Hydrogels offer advantages like high water content and flexibility for drug formulation.
  • Meloxicam is a non-steroidal anti-inflammatory drug used for pain and inflammation.

Purpose of the Study:

  • To formulate and evaluate meloxicam-loaded hydrogels for topical application.
  • To investigate the impact of penetration enhancers on meloxicam release.
  • To compare the efficacy of different penetration enhancers in hydrogel formulations.

Main Methods:

  • Hydrogels were prepared using carbopol-940 and carbopol-934 as polymers.
  • Various penetration enhancers (tween 80, oleic acid, sesame oil) were incorporated at 1% and 2% concentrations.
  • Formulations were evaluated for physical properties, drug content, in vitro drug permeation through pig skin, and stability.

Main Results:

  • All formulations exhibited good homogeneity and drug content above 93%.
  • Formulation F(14) with carbopol-934 and 2% sesame oil showed 99% drug release, following zero-order kinetics.
  • Increased penetration enhancer concentration correlated with higher drug release rates.

Conclusions:

  • Sesame oil at 2% concentration significantly enhanced meloxicam release from carbopol-934 hydrogels.
  • The developed hydrogels demonstrate potential for effective topical delivery of meloxicam.
  • Further studies are warranted to explore in vivo efficacy and safety.